Xcyton Diagnostics Private Limited

XCyton is a molecular diagnostics lab & research center providing diagnostic tests in critical infections. We developed & patented 'Syndrome Evaluation System' or SES, world's 1st pathogen detection system that simultaneously detects all probable causative agents of critical infections - Bacteria, Fungi, Viruses and Parasites – from a single sample, in a single test, within 7 hrs. SES is for Syndromes likes Sepsis, Pneumonia, Encephalitis, Meningitis, Post Transplant Infections, Uveitis, Endophthalmitis, Retinitis, etc. SES answers these gaps: • Delay: Conventional tests takes >72 hrs SES does it in 7 hrs • Lack of Diagnosis: Conventional tests diagnose in 10-20% cases. SES does it in 70-75% cases • Inability to detect viruses, bacteria, fungi,parasites, etc in one test SES does precisely that • Antibiotic Resistance (ABR) SES detects ABR, helping early initiation of appropriate antibiotic. Guided therapy reduces ABR • Increased health care costs Early diagnosis leads to guided therapy, in turn leading to faster recoveries, reduction in medication, investigations and ICU stay. SES is the only molecular diagnostic test which is proven to reduce mortality, hospital stay & antibiotic usage in sepsis. It is the fastest test available to diagnose pathogens and antibiotic resistance. It specifically identifies pathogenic bugs. It is the only test to identify the exact gene responsible for notoriety of the bug. It is first and only Mol Dx test developed in house to be NABL accredited. XCyton belongs to the top 5% of all Mol Dx labs globally (Validated by QCMD, UK.) More than 300 hospitals in India rely on SES for critical infection diagnosis. We are the Most Awarded Mol Dx Lab in India. Our awards include:* Diagnostic Product of the Year - BioSpectrum * India Innovation Growth Program - DST Lockheed Martin * The Most Important Technology Developed in Asia - Bio Singapore * Technology Business Accelerator Award Winner - XLR8/AP Govt.